Technical Analysis for SESN - Sesen Bio, Inc.

Grade Last Price % Change Price Change
grade F 0.755 -1.92% -0.01
SESN closed down 1.92 percent on Wednesday, June 3, 2020, on 66 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Down
Historical SESN trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
MACD Bearish Signal Line Cross Bearish -1.92%
20 DMA Support Bullish -1.92%
Hammer Candlestick Bullish -1.92%
Wide Bands Range Expansion -1.92%
Wide Bands Range Expansion -5.63%
1,2,3 Pullback Bullish Bullish Swing Setup -6.12%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Sesen Bio, Inc., a late-stage clinical company, develops next-generation antibody-drug conjugate therapies for patients with cancer. It develops its products based on its Targeted Protein Therapeutics (TPTs) platform. The company's lead product candidate is Vicinium, a fusion protein that is in Phase III clinical trial for the treatment of high-grade non-muscle invasive bladder cancer. It also develops Vicinium in combination with Durvalumab, which is in Phase I clinical trial for the treatment of high-grade non-muscle invasive bladder cancer; and Vicinium in combination with AstraZeneca's checkpoint inhibitor for the treatment of squamous cell carcinoma of the head and neck. In addition, the company is developing systemically-administered TPTs, including VB6-845d for the treatment of solid tumors. The company was formerly known as Eleven Biotherapeutics, Inc. and changed its name to Sesen Bio, Inc. in May 2018. Sesen Bio, Inc. was founded in 2008 and is based in Cambridge, Massachusetts.
Medicine Cancer Oncology Solid Tumors Monoclonal Antibodies Astrazeneca Bladder Cancer Its Its Products Causes Of Death

Is SESN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.53
52 Week Low 0.37
Average Volume 1,069,297
200-Day Moving Average 0.93
50-Day Moving Average 0.64
20-Day Moving Average 0.76
10-Day Moving Average 0.80
Average True Range 0.06
ADX 33.37
+DI 27.80
-DI 19.13
Chandelier Exit (Long, 3 ATRs ) 0.75
Chandelier Exit (Short, 3 ATRs ) 0.75
Upper Bollinger Band 0.88
Lower Bollinger Band 0.63
Percent B (%b) 0.5
BandWidth 32.16
MACD Line 0.05
MACD Signal Line 0.05
MACD Histogram -0.0052
Fundamentals Value
Market Cap 11.62 Million
Num Shares 15.4 Million
EPS 0.11
Price-to-Earnings (P/E) Ratio 6.86
Price-to-Sales 0.56
Price-to-Book 1.03
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.83
Resistance 3 (R3) 0.83 0.81 0.82
Resistance 2 (R2) 0.81 0.79 0.81 0.81
Resistance 1 (R1) 0.78 0.77 0.77 0.78 0.81
Pivot Point 0.76 0.76 0.75 0.76 0.76
Support 1 (S1) 0.73 0.74 0.72 0.73 0.70
Support 2 (S2) 0.70 0.72 0.70 0.70
Support 3 (S3) 0.68 0.70 0.69
Support 4 (S4) 0.68